26-(2-diethylaminoethyl)sulfonylpristamycin IIB,
dalfopristin,
RP 54476,
RP-54476,
DALFOPRISTIN,
Dalfopristina,
Dalfopristine,
Dalfopristinum,
UNII-R9M4FJE48E,
112362-50-2,
R9M4FJE48E,
RP 54476,
Dalfopristine [INN-French],
Dalfopristinum [INN-Latin],
Dalfopristina [INN-Spanish],
5-(2-DIETHYLAMINO-ETHANESULFONYL)-21-HYDROXY-10-ISOPROPYL-11,19-DIMETHYL-9,26-DIOXA-3,15,28-TRIAZA-TRICYCLO[23.2.1.00,255]OCTACOSA-1(27),12,17,19,25(28)-PENTAENE-2,8,14,23-TETRAONE,
Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-,
dalfopristin mesylate,
Dalfopristin [USAN:INN:BAN],
HSDB 8068,
(3R,4R,5E,10E,12E,14S,26R,26aS)-26-((2-(Diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone,
DOL,
RP-54476,
DalfopristinDISCONTINUED,
SCHEMBL40993,
CHEMBL1200937,
ZINC3917540,
AN-5606,
DB01764,
(26R,27S)-26-[[2-(diethylamino)ethyl]sulfonyl]-26,27-dihydrovirginiamycin M1,
UNII-C49WS9N75L component SUYRLXYYZQTJHF-VMBLUXKRSA-N,
2-diethylaminoethylsulfonyl-hydroxy-isopropyl-dimethyl-[?]tetrone,
(3R,4R,5E,10E,12E,14S,26R,26aS)-26-[[2-(Diethylamino)ethyl]sulfonyl]-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone,
(3R,4R,5E,10E,12E,14S,26R,26aS)-26-{[2-(diethylamino)ethyl]sulfonyl}-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25,26,26a-octahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone,
Dalfopristin [USAN:INN],
D05AFC,
C34H50N4O9S,
C34-H50-N4-O9-S,